Health
Moderna Covid vaccine efficacy falls slightly to 90% in US trial – Yahoo News Australia
US biotech company Moderna announced Covid vaccine is 90 percent effective against all forms of the disease and 95 percent effective against severe disease.
US biotech company Moderna announced Covid vaccine is 90 percent effective against all forms of the disease and 95 percent effective against severe disease.
The new results come from its ongoing Phase 3 clinical trial involving more 30,000 people across the United States, and the headline efficacy figure is a slight decrease from an earlier figure of 94.1 percent published in the New England Journal of Medicine in December.
The new number is based on 900 adjudicated cases of Covid from the study…
-
Noosa News23 hours agoMeasles alert issued south of Brisbane after traveller tests positive
-
General23 hours agoArtists brace as AI, the greatest theft in history, swamps us now
-
General24 hours agoMother and son facing trial for kidnapping her two younger sons appear in ACT Supreme Court
-
Business10 hours agoWarning! These ASX 200 shares were just downgraded